Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France

An indirect in-house immunofluorescent assay was developed in order to assess the serological status of COVID-19 patients in Marseille, France. Performance of IFA was compared to a commercial ELISA IgG kit. We tested 888 RT-qPCR-confirmed COVID-19 patients (1302 serum samples) and 350 controls inclu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Clin Microbiol Infect Dis
Main Authors: Edouard, S., Colson, P., Melenotte, C., Di Pinto, F., Thomas, L., La Scola, B., Million, M., Tissot-Dupont, H., Gautret, P., Stein, A., Brouqui, P., Parola, P., Lagier, J.-C., Raoult, D., Drancourt, Michel
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657073/
https://ncbi.nlm.nih.gov/pubmed/33179133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10096-020-04104-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados